With your own knowledge and the help of the following document:

Document 1 (Title: Immunological Function of Major Histocompatibility Complex): Major histocompatibility complex (MHC) molecules represent critical components of adaptive immunity with distinctive structural and functional characteristics determining their roles in immune recognition processes. Class II histocompatibility molecules demonstrate specific cellular expression patterns predominantly on professional antigen-presenting cells including dendritic cells, macrophages, and B lymphocytes. This restricted distribution pattern contrasts with the nearly ubiquitous expression of class I molecules encoded by HLA-A, B, and C loci. Structural analysis reveals class II molecules comprise non-covalently associated alpha and beta chains, both encoded within the MHC genetic region, rather than incorporating the non-MHC-encoded beta-2-microglobulin component characteristic of class I structures. This heterodimeric architecture creates a distinctive peptide-binding groove accommodating longer peptide fragments compared to class I molecules. Functional studies demonstrate critical roles in exogenous antigen presentation, with class II molecules primarily binding peptides derived from endocytosed and proteolytically processed extracellular proteins. The resulting MHC-peptide complexes interact specifically with T-cell receptors on CD4-positive helper T cells, with the CD4 molecule serving as a co-receptor through direct interaction with class II molecules rather than as their primary ligand. This interaction architecture enables specific recognition of extracellular pathogens and subsequent orchestration of appropriate immune responses through cytokine production and B-cell help. Genetic polymorphism within class II loci contributes to variable disease susceptibility patterns and transplantation compatibility, highlighting their fundamental importance in immunological function and clinical outcomes spanning infectious disease, autoimmunity, and transplantation medicine.
Document 2 (Title: Structural and Functional Aspects of Immunoglobulin Classes): Immunoglobulin D (IgD) represents a distinct antibody class with unique structural characteristics and biological functions within the adaptive immune system. Comparative analysis with other immunoglobulin classes reveals several distinguishing features influencing its physiological roles. Unlike IgE, which plays central roles in immediate hypersensitivity reactions through mast cell and basophil binding leading to mediator release in anaphylactic processes, IgD demonstrates minimal involvement in classical hypersensitivity reactions. Structural analysis through protein crystallography and electron microscopy reveals that IgD heavy chains contain four constant domains (CH1, CH2, CH3, and CH4) rather than the five-domain structure observed in certain other immunoglobulin classes, maintaining the standard antibody architectural pattern with variable regions determining antigen specificity. In contrast to predominantly pentameric IgM and dimeric IgA, IgD exists primarily in monomeric form with the characteristic four-chain structure comprising two heavy and two light chains linked through disulfide bonds. Cellular expression patterns demonstrate that IgD serves predominantly as a membrane-bound antigen receptor on mature B lymphocytes, where it functions alongside IgM as part of the B-cell receptor complex involved in antigen recognition and cellular activation rather than functioning primarily as a secreted antibody. This membrane localization distinguishes it from predominantly secreted immunoglobulins like IgG. Molecular weight analysis through ultracentrifugation and gel filtration chromatography confirms that IgD possesses a molecular mass ranging between approximately 160-190 kDa, placing it in an intermediate position between lighter antibody classes like IgG and heavier structures like pentameric IgM. These distinctive characteristics inform understanding of IgD's specialized roles in B-cell biology and adaptive immune regulation.
Document 3 (Title: Toxin-Mediated Bacterial Diseases and Immunoprophylaxis): Diphtheria, caused by toxigenic strains of Corynebacterium diphtheriae, represents a paradigmatic toxin-mediated bacterial disease with distinctive pathophysiological mechanisms and immunological considerations. While relatively uncommon in developed nations due to widespread immunization, the disease remains endemic in regions with suboptimal vaccination coverage, presenting substantial morbidity and mortality, particularly in pediatric populations. The pathogenesis centrally involves exotoxin production by C. diphtheriae strains lysogenized with a bacteriophage carrying the tox gene. The diphtheria toxin, a single polypeptide comprising two functional domains, initially binds to cell surface receptors via its B-fragment, facilitating entry of the catalytic A-fragment into the cytoplasm. The A-fragment catalyzes ADP-ribosylation of elongation factor 2, irreversibly inhibiting protein synthesis and inducing cellular apoptosis. Local infection typically manifests as a distinctive gray-white pseudomembranous pharyngitis with regional lymphadenopathy, while toxin-mediated systemic complications include myocarditis and peripheral neuropathy, which account for the majority of fatalities. Immunization against diphtheria utilizes formaldehyde-treated toxin (toxoid) to induce neutralizing antibodies directed against the B-fragment, preventing cellular binding and internalization. This humoral immunity, mediated by circulating IgG antibodies, provides effective protection against toxin-mediated manifestations but does not prevent colonization by toxigenic strains. Protective efficacy correlates directly with antitoxin antibody titers, with levels exceeding 0.01 IU/mL considered protective. The conventional immunization schedule includes primary series administration during infancy followed by periodic boosters to maintain protective antibody levels throughout life. In contrast to cellular immunity (mediated by CD4+ T lymphocytes) or mucosal protection (mediated by secretory IgA), which play predominant roles in defense against intracellular pathogens and mucosal colonizers respectively, protection against diphtheria principally relies on circulating neutralizing antibodies interfering with toxin-receptor interaction. Unimmunized or inadequately immunized individuals remain susceptible to both localized disease and potentially lethal systemic complications through toxin dissemination.

Answer the following list question.
Question: Select the correct statement(s): Class II histocompatibility molecules:
Options:
1. Are encoded by genes present at the HLA-A, -B and -C loci
2. Are expressed on B lymphocytes and monocyte macrophages
3. Are formed by an alpha chain associated with beta-2 microglobulin
4. Have CD4 molecule as a ligand
5. Are involved in antigen presentation

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ‚Üê if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.